FOSTER CITY, Calif .– (COMMERCIAL THREAD) – Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, MD, President and CEO of Geron, is scheduled to present at the following investor conferences:
HC Wainwright 23rd Annual Global Virtual Investing Conference Monday, September 13, 2021 at 7 a.m. ET.
RW Baird 2021 Virtual Global Healthcare Conference on Tuesday, September 14, 2021 at 2:00 p.m. ET.
2021 Cantor Virtual Global Healthcare Conference Thursday, September 30, 2021 at 3:20 p.m. ET.
A live webcast of each presentation will be available through the Investor Relations section of Geron’s website under Events. Following the presentations, the webcasts will be archived and available to replay for a period of 30 days.
Geron is an advanced-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-class telomerase inhibitor, imetelstat, in malignant myeloid hematologic disease. The Company is currently conducting two phase 3 clinical trials: IMerge in low-risk myelodysplastic syndromes and IMpactMF in refractory myelofibrosis. For more information on Géron, visit www.geron.com.